Difference between revisions of "CT Coordinating Committee"
Jump to navigation
Jump to search
m (→Scope) |
m (→Scope) |
||
| Line 14: | Line 14: | ||
:::* [[CT_Volumetry_Biomarker_Ctte#Lung_Nodule_Assessment_in_CT_Screening|Lung Nodule Assessment in CT Screening]] | :::* [[CT_Volumetry_Biomarker_Ctte#Lung_Nodule_Assessment_in_CT_Screening|Lung Nodule Assessment in CT Screening]] | ||
::* [[Lung Density Biomarker Ctte]] | ::* [[Lung Density Biomarker Ctte]] | ||
| − | ::*CT Small Lung Nodule Biomarker Committee | + | ::* CT Small Lung Nodule Biomarker Committee |
| − | ::* | + | ::* CT Angiography Biomarker Committee |
==Meetings== | ==Meetings== | ||
* Zoom calls are held Quarterly. Please contact RSNA Staff for details. | * Zoom calls are held Quarterly. Please contact RSNA Staff for details. | ||
Revision as of 22:34, 17 May 2022
Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD
RSNA Staff Support: Julie Lisiecki
Scope
The CT Coordinating Committee is responsible for:
- Monitoring and coordinating the activities of CT Biomarker Committees
- QIBA Profile Dashboard (CT Page)
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the CT Biomarker Committees
-
- Lung Density Biomarker Ctte
- CT Small Lung Nodule Biomarker Committee
- CT Angiography Biomarker Committee
Meetings
- Zoom calls are held Quarterly. Please contact RSNA Staff for details.